FDA Updates OxyContin Label, Blocks Generics

(MedPage Today) -- The FDA has issued new labeling information for OxyContin -- on the same day the patent on the original formulation expired, thus blocking potential generic versions that do not have abuse-deterrent properties. (Source: MedPage Today Psychiatry)

via Original Article